IXICO plc
PHYOF · OTC
9/30/2025 | 3/31/2025 | 9/30/2024 | 3/31/2024 | |
|---|---|---|---|---|
| Market Cap | $4 | $5 | $3 | $6 |
| - Cash | $4 | $5 | $2 | $3 |
| + Debt | $0 | $0 | $0 | $0 |
| Enterprise Value | $1 | -$0 | $1 | $4 |
| Revenue | – | $3 | $3 | $3 |
| % Growth | – | -0.6% | 27.2% | – |
| Gross Profit | – | $2 | $2 | $1 |
| % Margin | – | 49.6% | 48.4% | 40.2% |
| EBITDA | – | -$1 | -$0 | -$1 |
| % Margin | – | -22.5% | -9.4% | -53.1% |
| Net Income | – | -$1 | -$1 | -$1 |
| % Margin | – | -29.9% | -18.2% | -55.7% |
| EPS Diluted | – | -0.011 | -0.012 | -0.029 |
| % Growth | – | 9% | 58.2% | – |
| Operating Cash Flow | – | -$0 | -$1 | -$1 |
| Capital Expenditures | – | -$0 | -$0 | -$0 |
| Free Cash Flow | – | -$0 | -$1 | -$1 |